Clinical Trial Update: Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Psoralait to placebo for psoriasis has been terminated; the update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Psoralait

Snippet

Sponsor: Trima, Israel Pharmaceutical Products | Conditions: Psoriasis | Phase 4 | Status: TERMINATED